Light-Responsive Pt(IV) Prodrugs with Controlled Photoactivation and Low Dark Toxicity.
BODIPY
PET
cisplatin
photoactivation
prodrug
Journal
ACS applied bio materials
ISSN: 2576-6422
Titre abrégé: ACS Appl Bio Mater
Pays: United States
ID NLM: 101729147
Informations de publication
Date de publication:
02 May 2024
02 May 2024
Historique:
medline:
3
5
2024
pubmed:
3
5
2024
entrez:
2
5
2024
Statut:
aheadofprint
Résumé
Light-induced release of cisplatin from Pt(IV) prodrugs represents a promising approach for precise control over the antiproliferative activity of Pt-based chemotherapeutic drugs. This method has the potential to overcome crucial drawbacks of conventional cisplatin therapy, such as high general toxicity toward healthy organs and tissues. Herein, we report two Pt(IV) prodrugs with BODIPY-based photoactive ligands
Identifiants
pubmed: 38697834
doi: 10.1021/acsabm.4c00345
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM